Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	25.53B
Revenue (ttm)	153.35B
Net Income (ttm)	2.94B
Shares Out	4.99B
EPS (ttm)	0.58
PE Ratio	8.83
Forward PE	9.39
Dividend	0.20 (3.93%)
Ex-Dividend Date	Jun 17, 2025

Volume	15,264,931
Average Volume	23,515,423
Open	5.08
Previous Close	5.09
Day's Range	5.07 - 5.15
52-Week Range	4.35 - 6.31
Beta	0.30
RSI	46.18
Earnings Date	Aug 26, 2025

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines. The company was founded in 1999 and is based in Wuhan, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 30,169
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2024, SHA:600998's revenue was 151.81 billion, an increase of 1.11% compared to the previous year's 150.14 billion. Earnings were 2.51 billion, an increase of 15.33%.